Wangbing D. Chen
Cancer Center Union Hospital
Wuhan, China
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
CPSF4 promotes tumor-initiating phenotype by enhancing VEGF/NRP2/TAZ signaling in lung cancer.
Journal: Medical oncology (Northwood, London, England)
Published: September 21, 2022
Application of radiomics captured from CT to predict the EGFR mutation status and TKIs therapeutic sensitivity of advanced lung adenocarcinoma
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: April 25, 2019
RBFOX3 Regulates the Chemosensitivity of Cancer Cells to 5-Fluorouracil via the PI3K/AKT, EMT and Cytochrome-C/Caspase Pathways.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: July 27, 2017
Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
Journal: Molecular cancer
Published: January 18, 2017
RFPL3 and CBP synergistically upregulate hTERT activity and promote lung cancer growth.
Journal: Oncotarget
Published: March 21, 2015
Transcriptional coactivator CBP upregulates hTERT expression and tumor growth and predicts poor prognosis in human lung cancers.
Journal: Oncotarget
Published: October 09, 2014
Ret finger protein-like 3 promotes tumor cell growth by activating telomerase reverse transcriptase expression in human lung cancer cells.
Journal: Oncotarget
Published: August 10, 2014
TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling.
Journal: Molecular cancer
Published: January 03, 2014
TFAP2A regulates nasopharyngeal carcinoma growth and survival by targeting HIF-1α signaling pathway.
TFAP2A regulates nasopharyngeal carcinoma growth and survival by targeting HIF-1α signaling pathway.
Journal: Cancer prevention research (Philadelphia, Pa.)
Published: December 17, 2013
CPSF4 activates telomerase reverse transcriptase and predicts poor prognosis in human lung adenocarcinomas.
Journal: Molecular oncology
Published: October 09, 2013
Upregulation of cleavage and polyadenylation specific factor 4 in lung adenocarcinoma and its critical role for cancer cell survival and proliferation.
Journal: PloS one
Published: September 25, 2013
Last Updated: 09/26/2026